Skip to main content
Fig. 5 | Breast Cancer Research

Fig. 5

From: The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer

Fig. 5

Microscopic evaluation of HIF1α (red) expression in tumor tissue from control (A, D), single dose therapy (B, E), and fractionated dose therapy (C, F) animals. Nuclei were counterstained with DAPI (blue). The black box inside the schematic tumor tissue illustrates the location of interest. Scale bar: 50 µm

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us